Related Experiment Video
Updated: Jul 13, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Incidence and risk factors of contrast-induced nephropathy in acute stroke patients undergoing computed tomography
Muhannad A Asiri1, Mohammed S Alqahtani1, Saeed A Alqahtani1
1From the Neurology unit (Asiri, Alharbi, Aqeeli, Alzahrani, Alwadai), Department of Medicine, King Fahad hospital, Jeddah, from the Neurology unit (Alqahtani M), Department of Medicine, Armed Forces Hospital-Southern Region, Khamis Mushait, and from the Unit of Neurology (Alqahtani S), College of Medicine, King Khalid University, Abha, Kingdom of Saudi Arabia.
Insights
Contrast-induced nephropathy (CIN) affects 8.2% of acute stroke patients undergoing CT angiography. Intracerebral hemorrhage and abnormal baseline creatinine significantly increase CIN risk, highlighting the need for careful patient management.
Area of Science:
- Nephrology
- Neurology
- Radiology
Background:
- Acute stroke management often involves contrast-enhanced imaging like Computed Tomography Angiography (CTA).
- Contrast-induced nephropathy (CIN) is a potential complication following contrast administration.
- Understanding CIN prevalence and risk factors in acute stroke patients is crucial for optimizing care.
Purpose of the Study:
- To determine the incidence of CIN in acute stroke patients undergoing brain CTA.
- To identify significant risk factors associated with CIN development in this population.
Main Methods:
- Retrospective analysis of acute stroke patients at King Fahad Hospital, Jeddah, from March to November 2022.
- Inclusion criteria: baseline creatinine, CTA within 24 hours of symptom onset, and follow-up creatinine within 5 days.
- Data analysis focused on identifying correlations between patient characteristics and CIN development.
Main Results:
- Out of 182 patients who underwent brain CTA, 8.24% developed CIN.
- Intracerebral hemorrhage (ICH) was associated with a 7-fold increased risk of CIN (OR=6.7).
- Abnormal baseline creatinine (OR=7.8) and hypertension (OR=2.1) significantly elevated CIN risk.
Conclusions:
- The incidence of CIN in acute stroke patients undergoing CTA is 8.2%.
- Key risk factors include ICH, abnormal baseline creatinine, and hypertension.
- Vigilance in managing these patients is essential to mitigate CIN risk and ensure optimal clinical outcomes.
Objectives:
To investigate the prevalence and risk factors linked to contrast-induced nephropathy in this specific patient population, aiming to ensure the highest quality of clinical care.
Methods:
In a retrospective analysis, all patients who presented with an acute stroke to King Fahad Hospital, Jeddah, Emergency Department from March until November 2022 and underwent Computed Tomography Angiography (CTA) brain, Inclusion criteria were as follows: a baseline creatinine results and CTA examination performed within 24 hours of symptom onset and an available early (<5 days after CTA) follow-up creatinine result.
Results:
Among 246 stroke patients in the emergency, 182 underwent brain CTA and 8.24% had Contrast-Induced Nephropathy (CIN). intracerebral hemorrhage (ICH) increased CIN risk 7-fold (OR=6.7; 95% CI: 1.23-33.3). Abnormal baseline raised CIN risk 8-fold (OR=7.8; 95% CI: 1.74-35.1). hypertension doubled the risk for CIN (OR=2.1; 95% CI: 1.26-6.98) CONCLUSION: The incidence of CIN was 8.2%, particularly elevated in patients with ICH, hypertension, tissue plasminogen administration, and abnormal baseline, necessitating vigilance in managing acute stroke cases.
More Related Videos
Related Concept Videos
Imaging Studies III: Computed Tomography
Imaging Studies for Cardiovascular System V: CT
Imaging Studies VII: Vascular Imaging
Radiological Investigation I: X-ray and CT
Cardiac Catheterization I: Pre-Procedure Overview
Acute Kidney Injury IV: Diagnostic Studies and Prevention

